HELX

Franklin Genomic Advancements ETF

Jan 29 • 11:13AM ET

36.55

-0.30 -0.83 %

Financial • Exchange Traded Fund • USA • CBOE

Category	Global or ExUS Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	Global	Return% 1Y	20.17%	Total Holdings	65	Perf Week	-4.07%
Sponsor	Franklin Templeton	ETF Type		Tags	equity	Return% 3Y	4.42%	AUM	23.95M	Perf Month	-0.67%
Fund Family		Bond Type		Tags	healthcare	Return% 5Y	-5.99%	NAV/sh		Perf Quarter	6.70%
Index	-	Average Maturity		Tags	genomics	Return% 10Y		52W High	38.17 -4.24%	Perf Half Y	30.08%
Index Weighting		Commodity Type		Tags	-	Return% SI		52W Low	23.74 53.96%	Perf YTD	0.67%
Active/Passive		Quant Type		Tags	-	Flows% 1M	8.45%	Volatility	0.81% 0.82%	Perf Year	21.45%
Dividend TTM	0.14 (0.39%)	ESG Type		Tags	-	Flows% 3M	8.45%	ATR (14)	0.48	Perf 3Y	14.65%
Dividend Ex-Date	Dec 30, 2025	Dividend Type		Sector/Theme		Flows% YTD	8.45%	RSI (14)	44.09	Perf 5Y	-25.33%
Dividend Gr. 3/5Y	- 95.56%	Structure Type		Region		Flows% 1Y		Beta	1.07	Perf 10Y	-
Expense	0.50%	Growth/Value		SMA20	-1.83%	Flows% 3Y		Rel Volume	0.96	Prev Close	36.85
Inverse/Leveraged		Market Cap		SMA50	-1.27%	Flows% 5Y		Avg Volume	2.00K	Price	36.55
IPO	Feb 27, 2020	Option/Short	Yes / No	SMA200	17.39%	Trades		Volume	798	Change	-0.83%

Nov-25-25 03:44AM	The Zacks Analyst Blog Highlights LLY, EPHE, BBC, HELX, XHS and SURI (Zacks)
Nov-24-25 10:00AM	Best-Performing ETFs of Last Week: Healthcare Rules (Zacks)
Nov-21-25 08:00AM	Inside the Recent Strength in Biotech ETFs (Zacks)
May-02-25 03:25AM	Aim To Keep Risk Modest And Quality High (Seeking Alpha)
Apr-30-25 04:35AM	3 Ways To Avoid The Eye Of The Equity Market Storm (Seeking Alpha)
05:45AM	Loading…
Apr-23-25 05:45AM	Rewiring Global Trade For Resilience And Growth (Seeking Alpha)
Apr-20-25 11:28AM	IDNA: The Cutting Edge Of Medical Science Is A Risky Investment (Seeking Alpha)
Apr-18-25 01:40PM	Institutional, Retail Investors Shed $27B In U.S. Stocks In Early April Sell-Off (Seeking Alpha)
Apr-04-25 08:30AM	How Will New Tariffs Impact Your Investment Portfolio In 2025? (Seeking Alpha) -5.44%
Apr-02-25 07:00AM	The Great Transformation: Riding The Wave Of Change (Seeking Alpha)
Apr-01-25 05:40AM	U.S. Consumers To Be Hit Hardest By Pharmaceutical Tariffs (Seeking Alpha)
Mar-28-25 06:05AM	Volatility Brings Changes To Market Leadership (Seeking Alpha)
Mar-20-25 04:32PM	How ESG Policies Can Keep The Healthcare Sector Fighting Fit (SeekingAlpha)
Jul-16-21 11:19AM	Blockchain will be hugely disruptive to the finance industry: Jenny Johnson (Yahoo Finance Video)
Jan-14-21 09:15AM	Franklin Adds To Thematic ETF Line (ETF.com)
08:00AM	Loading…
Oct-05-20 08:00AM	Franklin Templeton Gives Matt Moberg Three New Funds To Run (Investor's Business Daily)

Franklin Genomic Advancements ETF seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.

open in yahoo | open in marketwatch | open in google

HELX

Franklin Genomic Advancements ETF

Upgrade your FINVIZ experience